Biomedical reports最新文献

筛选
英文 中文
Role of the SARS‑COV2 infection in the evolution of acute pancreatitis (Review). SARS - COV2感染在急性胰腺炎演变中的作用(综述)
IF 2.3
Biomedical reports Pub Date : 2023-07-01 DOI: 10.3892/br.2023.1632
Vlad Pădureanu, Daniel Cosmin Caragea, Mirela Marinela Florescu, Ionela Mihaela Vladu, Patricia Mihaela Rădulescu, Dan Nicolae Florescu, Dumitru Rădulescu, Rodica Pădureanu, Ion Cristian Efrem
{"title":"Role of the SARS‑COV2 infection in the evolution of acute pancreatitis (Review).","authors":"Vlad Pădureanu,&nbsp;Daniel Cosmin Caragea,&nbsp;Mirela Marinela Florescu,&nbsp;Ionela Mihaela Vladu,&nbsp;Patricia Mihaela Rădulescu,&nbsp;Dan Nicolae Florescu,&nbsp;Dumitru Rădulescu,&nbsp;Rodica Pădureanu,&nbsp;Ion Cristian Efrem","doi":"10.3892/br.2023.1632","DOIUrl":"https://doi.org/10.3892/br.2023.1632","url":null,"abstract":"<p><p>Acute pancreatitis is characterized as an inflammatory illness that is life-threatening and causes necrosis as well as simple edema when pancreatic enzymes are activated intraglandularly. It is not known whether severe acute respiratory syndrome coronavirus 2 causes acute pancreatitis. Patients with acute pancreatitis who test positive for coronavirus disease 2019 (COVID-19) frequently have biliary or alcoholic causes. It is unclear how common acute pancreatitis is in patients with COVID-19. By contrast with patients without COVID-19, however, COVID-19-positive patients with acute pancreatitis have a higher mortality as well as a higher risk of necrosis and admission to an intensive care unit. The most common cause of mortality in COVID-19-positive individuals with concurrent severe pancreatitis is acute respiratory distress syndrome. The present study discussed research on the link between COVID-19 infection and acute pancreatitis.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"19 1","pages":"49"},"PeriodicalIF":2.3,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/38/e9/br-19-01-01632.PMC10293881.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10291775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Exploring the optimal vaccination strategy against hepatitis B virus in childhood (Review). 探索儿童乙型肝炎病毒的最佳疫苗接种策略(综述)。
IF 2.3
Biomedical reports Pub Date : 2023-07-01 DOI: 10.3892/br.2023.1631
Anna Kramvis, Ioannis N Mammas, Demetrios A Spandidos
{"title":"Exploring the optimal vaccination strategy against hepatitis B virus in childhood (Review).","authors":"Anna Kramvis,&nbsp;Ioannis N Mammas,&nbsp;Demetrios A Spandidos","doi":"10.3892/br.2023.1631","DOIUrl":"https://doi.org/10.3892/br.2023.1631","url":null,"abstract":"<p><p>Vaccination against hepatitis B virus (HBV) remains the most effective strategy against HBV infection in humans. The present review summarized the optimal vaccination strategies against HBV in childhood. The following points are discussed: i) When and how the first HBV vaccines were developed; ii) the dosages, schedules and injection routes that are used for HBV vaccination; iii) the contraindications for HBV vaccination in the general paediatric population; iv) the challenges with the use of multivalent vaccines; v) the long-term immunogenicity and duration of protection against HBV; vi) the use of selective HBV vaccination and the hepatitis B immune globulin strategy in HBV-exposed infants; and vii) the effectiveness of the current HBV vaccination schemes. The present review is based on a Paediatric Virology Study Group (PVSG) webinar performed in the context of the 8th Workshop on Paediatric Virology.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"19 1","pages":"48"},"PeriodicalIF":2.3,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d3/38/br-19-01-01631.PMC10293880.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10113422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gemcitabine‑fucoxanthin combination in human pancreatic cancer cells. 吉西他滨-岩藻黄素组合在人胰腺癌细胞中的作用。
IF 2.3
Biomedical reports Pub Date : 2023-07-01 DOI: 10.3892/br.2023.1629
Jun Lu, Xiaowu Jenifer Wu, Amira Hassouna, Kelvin Sheng Wang, Yan Li, Tao Feng, Yu Zhao, Minfeng Jin, Baohong Zhang, Tianlei Ying, Jinyao Li, Lufeng Cheng, Johnson Liu, Yue Huang
{"title":"Gemcitabine‑fucoxanthin combination in human pancreatic cancer cells.","authors":"Jun Lu,&nbsp;Xiaowu Jenifer Wu,&nbsp;Amira Hassouna,&nbsp;Kelvin Sheng Wang,&nbsp;Yan Li,&nbsp;Tao Feng,&nbsp;Yu Zhao,&nbsp;Minfeng Jin,&nbsp;Baohong Zhang,&nbsp;Tianlei Ying,&nbsp;Jinyao Li,&nbsp;Lufeng Cheng,&nbsp;Johnson Liu,&nbsp;Yue Huang","doi":"10.3892/br.2023.1629","DOIUrl":"https://doi.org/10.3892/br.2023.1629","url":null,"abstract":"<p><p>Gemcitabine is a chemotherapeutic agent for pancreatic cancer treatment. It has also been demonstrated to inhibit human pancreatic cancer cell lines, MIA PaCa-2 and PANC-1. The aim of the present study was to investigate the suppressive effect of fucoxanthin, a marine carotenoid, in combination with gemcitabine on pancreatic cancer cells. MTT assays and cell cycle analysis using flow cytometry were performed to study the mechanism of action. The results revealed that combining a low dose of fucoxanthin with gemcitabine enhanced the cell viability of human embryonic kidney cells, 293, while a high dose of fucoxanthin enhanced the inhibitory effect of gemcitabine on the cell viability of this cell line. In addition, the enhanced effect of fucoxanthin on the inhibitory effect of gemcitabine on PANC-1 cells was significant (P<0.01). Fucoxanthin combined with gemcitabine also exerted significant enhancement of the anti-proliferation effect in MIA PaCa-2 cells in a concentration dependent manner (P<0.05), compared with gemcitabine treatment alone. In conclusion, fucoxanthin improved the cytotoxicity of gemcitabine on human pancreatic cancer cells at concentrations that were not cytotoxic to non-cancer cells. Thus, fucoxanthin has the potential to be used as an adjunct in pancreatic cancer treatment.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"19 1","pages":"46"},"PeriodicalIF":2.3,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/49/41/br-19-01-01629.PMC10265583.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer. 程序性死亡配体1在阴茎癌肿瘤细胞和肿瘤浸润淋巴细胞中的表达与肿瘤浸润深度相关。
IF 2.3
Biomedical reports Pub Date : 2023-07-01 DOI: 10.3892/br.2023.1627
Sakkarn Sangkhamanon, Natcha Kotano, Wichien Sirithanaphol, Ukrit Rompsaithong, Pakorn Kiatsopit, Aumkhae Sookprasert, Kosin Wirasorn, Prin Twinprai, Piyakarn Watcharenwong, Jarin Chindaprasirt
{"title":"Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer.","authors":"Sakkarn Sangkhamanon,&nbsp;Natcha Kotano,&nbsp;Wichien Sirithanaphol,&nbsp;Ukrit Rompsaithong,&nbsp;Pakorn Kiatsopit,&nbsp;Aumkhae Sookprasert,&nbsp;Kosin Wirasorn,&nbsp;Prin Twinprai,&nbsp;Piyakarn Watcharenwong,&nbsp;Jarin Chindaprasirt","doi":"10.3892/br.2023.1627","DOIUrl":"https://doi.org/10.3892/br.2023.1627","url":null,"abstract":"<p><p>The present study aimed to demonstrate the proportion of the programmed death-ligand 1 (PD-L1) expression in penile cancer patients and the association with clinicopathological parameters. Formalin-fixed paraffin-embedded specimens were obtained from 43 patients with primary penile squamous cell carcinoma treated at Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, between 2008 and 2018. PD-L1 expression was evaluated by the immunohistochemistry using an SP263 monoclonal antibody. PD-L1 positivity was defined as >25% tumor cell staining or >25% tumor-associated immune cell staining. The correlation between PD-L1 expression and clinicopathological parameters was analyzed. A total of eight of 43 patients (18.6%) were identified as positive for PD-L1 expression in tumor cells and tumor-infiltrating lymphocytes. In the PD-L1 positive group, there was a significant association with pathological T stage (P=0.014) with a higher percentage of PD-L1 positive tumors in T1 stage compared with T2-T4 stage. In this cohort, there was a trend towards longer survival in patients with positive PD-L1 expression (5-year OS: 75% vs. 61.2%, P=0.19). Lymph node involvement and the location of tumor at the shaft of penis were two independent prognostic factors for survival. In conclusion, the PD-L1 expression was detected in 18% of penile cancer patients and high expression of PD-L1 was associated with the early T stage.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"19 1","pages":"44"},"PeriodicalIF":2.3,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0f/53/br-19-01-01627.PMC10265570.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new use of transcutaneous electrical nerve stimulation: Role of bioelectric technology in resistant hypertension (Review). 经皮神经电刺激的新应用:生物电技术在顽固性高血压中的作用(综述)。
IF 2.3
Biomedical reports Pub Date : 2023-06-01 DOI: 10.3892/br.2023.1621
Chenghua Wang, Pu Wang, Guoqing Qi
{"title":"A new use of transcutaneous electrical nerve stimulation: Role of bioelectric technology in resistant hypertension (Review).","authors":"Chenghua Wang,&nbsp;Pu Wang,&nbsp;Guoqing Qi","doi":"10.3892/br.2023.1621","DOIUrl":"https://doi.org/10.3892/br.2023.1621","url":null,"abstract":"<p><p>Hypertension is an important risk factor for cardiovascular and cerebrovascular disease-associated death. Hypertension and its complications are the main problems that have an impact on public health at present. A portion of adults with hypertension fail to meet the recommended blood pressure (BP) treatment goals, despite strict clinical management. Those individuals requiring at least three types of antihypertensive drugs to achieve their BP goal may be classified as patients with resistant hypertension (RH). Bioelectric technology is an emerging method that functions with the help of the human body's own bioelectric system. It is widely used in auxiliary examination, pain relief and organ function rehabilitation. Bioelectrical technology, as an effective treatment for RH, has developed rapidly in recent years and mainly includes renal sympathetic denervation, carotid baroreflex activation therapy, Traditional Chinese Medicine electroacupuncture and transcutaneous electrical nerve stimulation (TENS). The present review describes the pathogenesis of hypertension and provides an understanding of bioelectrical technology as a treatment. In particular, the development of the application of TENS in RH is introduced. The aim is to provide a basis for the clinical treatment of RH and a new idea for further clinical trials in this field.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"18 6","pages":"38"},"PeriodicalIF":2.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/5f/br-18-06-01621.PMC10165504.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9507687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ST‑segment elevation associated with intraparenchymal hemorrhage: A case report. ST段抬高与肺实质出血相关:1例报告。
IF 2.3
Biomedical reports Pub Date : 2023-06-01 DOI: 10.3892/br.2023.1622
Manuel Alejandro Giraldo-Delgado, Mateo Zuluaga-Gómez, Daniel González-Arroyave, Carlos M Ardila
{"title":"ST‑segment elevation associated with intraparenchymal hemorrhage: A case report.","authors":"Manuel Alejandro Giraldo-Delgado,&nbsp;Mateo Zuluaga-Gómez,&nbsp;Daniel González-Arroyave,&nbsp;Carlos M Ardila","doi":"10.3892/br.2023.1622","DOIUrl":"https://doi.org/10.3892/br.2023.1622","url":null,"abstract":"<p><p>The electrocardiogram (ECG) changes in patients with intraparenchymal hemorrhage (IPH) have remained largely elusive and no case reports are currently available in the scientific literature. The medical management of a patient with ST-segment elevation associated with IPH was described in the present study. The case report describes a 78-year-old male patient who presented with ST-segment elevation in V1, V2, V3 and V4 on ECG. Initially, the case was managed therapeutically as an acute myocardial infarction. Later, the patient was transferred to a higher-level hospital, where a new ECG confirmed ST-segment elevation. Simple skull tomography was also performed, which revealed a spontaneous right basal ganglion in the context of an acute cerebrovascular accident of hypertensive origin. A transthoracic ECG was ordered, which revealed an ejection fraction of 65% with type I diastolic dysfunction due to relaxation disorders and without any signs of ischemia, intracavitary masses or thrombi. In addition to the presence of nonspecific ECG findings, clinicians should consider immediate brain computed tomography to confirm intracranial hemorrhage.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"18 6","pages":"39"},"PeriodicalIF":2.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189584/pdf/br-18-06-01622.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9499320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histological features of knee osteoarthritis treated with triamcinolone acetonide and hyaluronic acid. 曲安奈德与透明质酸治疗膝关节骨性关节炎的组织学特征。
IF 2.3
Biomedical reports Pub Date : 2023-06-01 DOI: 10.3892/br.2023.1623
Pattaranatcha Charnwichai, Rachaneekorn Tammachote, Nattapol Tammachote, Thiamjit Chaichana, Nakarin Kitkumthorn
{"title":"Histological features of knee osteoarthritis treated with triamcinolone acetonide and hyaluronic acid.","authors":"Pattaranatcha Charnwichai,&nbsp;Rachaneekorn Tammachote,&nbsp;Nattapol Tammachote,&nbsp;Thiamjit Chaichana,&nbsp;Nakarin Kitkumthorn","doi":"10.3892/br.2023.1623","DOIUrl":"https://doi.org/10.3892/br.2023.1623","url":null,"abstract":"<p><p>Osteoarthritis (OA) is one of the most common degenerative joint diseases leading to disability in the end stage. Although intra-articular triamcinolone acetonide (TA) is one of the OA treatments that have been widely used, the side effects of such corticosteroids are still controversial. Intra-articular hyaluronic acid (HA) injection is another therapeutic option for patients with OA who do not want to use corticosteroids because of their side effects. However, the difference between the histological features associated with TA and HA in the treatment of OA remains unclear. Thus, the present study aimed to compare the histological effects of TA and HA on the cartilage of patients with knee OA. In the current study, 31 patients diagnosed with grade 3-4 knee OA on the Kellgren-Lawrence radiographic grading scale were separated into three groups: TA (n=12); HA (n=7) and untreated group (n=12). Histological examination of the whole articular cartilages of the patients was performed with hematoxylin and eosin and Alcian staining, as well as using a TUNEL assay. Clinical data such as cartilage thickness, structural and component deterioration, proteoglycan levels, apoptosis and empty lacunae were compared between the three groups. The results showed a high level of deterioration in both TA and HA groups but not in the untreated group, although the thickness of cartilage in the HA group was lower compared with that in the TA and untreated groups. The proteoglycan levels in the TA group were lower compared with those in the HA group. Moreover, the number of empty lacunae in the HA group was higher compared with that in the TA group, while no difference in apoptosis was found between TA and HA groups. A significant difference was not found in the histological staining between TA and HA groups. On the other hand, a significant difference was found in cartilage deterioration between the medial and lateral sides in these groups. TA and HA groups showed comparable histological results. TA injection is cheaper and easier but has more adverse effects for patients with knee OA than HA injection. Therefore, orthopaedists should select TA or HA based on the economic and specific needs of patients.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"18 6","pages":"40"},"PeriodicalIF":2.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/56/83/br-18-06-01623.PMC10203754.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9526474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies for in situ tissue engineering of vascularized bone regeneration (Review). 血管化骨再生原位组织工程策略(综述)。
IF 2.3
Biomedical reports Pub Date : 2023-06-01 DOI: 10.3892/br.2023.1625
Yijun He, Lin Liang, Cheng Luo, Zhi-Yong Zhang, Jiongfeng Huang
{"title":"Strategies for <i>in situ</i> tissue engineering of vascularized bone regeneration (Review).","authors":"Yijun He,&nbsp;Lin Liang,&nbsp;Cheng Luo,&nbsp;Zhi-Yong Zhang,&nbsp;Jiongfeng Huang","doi":"10.3892/br.2023.1625","DOIUrl":"https://doi.org/10.3892/br.2023.1625","url":null,"abstract":"<p><p>Numerous physiological processes occur following bone fracture, including inflammatory cell recruitment, vascularization, and callus formation and remodeling. In particular circumstances, such as critical bone defects or osteonecrosis, the regenerative microenvironment is compromised, rendering endogenous stem/progenitor cells incapable of fully manifesting their reparative potential. Consequently, external interventions, such as grafting or augmentation, are frequently necessary. <i>In situ</i> bone tissue engineering (iBTE) employs cell-free scaffolds that possess microenvironmental cues, which, upon implantation, redirect the behavior of endogenous stem/progenitor cells towards a pro-regenerative inflammatory response and reestablish angiogenesis-osteogenesis coupling. This process ultimately results in vascularized bone regeneration (VBR). In this context, a comprehensive review of the current techniques and modalities in VBR-targeted iBTE technology is provided.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"18 6","pages":"42"},"PeriodicalIF":2.3,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e0/ae/br-18-06-01625.PMC10265129.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gut and reproductive tract microbiota: Insights into the pathogenesis of endometriosis (Review). 肠道和生殖道微生物群:子宫内膜异位症发病机制的启示(综述)。
IF 2.3
Biomedical reports Pub Date : 2023-05-29 eCollection Date: 2023-07-01 DOI: 10.3892/br.2023.1626
Hiroshi Kobayashi
{"title":"Gut and reproductive tract microbiota: Insights into the pathogenesis of endometriosis (Review).","authors":"Hiroshi Kobayashi","doi":"10.3892/br.2023.1626","DOIUrl":"10.3892/br.2023.1626","url":null,"abstract":"<p><p>Endometriosis is characterized by the presence of endometrial-like tissue outside the uterus and is associated with an inflammatory immune response. The gut and reproductive tract microbiota constitute a protective barrier against infection by pathogens and regulate inflammatory and immune functions. This review summarizes microbiota imbalance (i.e., dysbiosis) in endometriosis and discusses how dysbiosis influences disease development. The literature was searched for studies published from inception to March 2022 in the PubMed and Google Scholar databases using a combination of specific terms. An altered gut and reproductive tract microbiome has been reported in numerous conditions, such as inflammatory bowel disease, allergies, autoimmunity, cancer and reproductive disorders (e.g., endometriosis). Furthermore, microbial dysbiosis is a hallmark of endometriosis and is characterized by a decrease in beneficial probiotics and an increase in pathogenic microbes, which leads to a series of estrobolomic and metabolomic changes. Gut or reproductive tract microbiome dysbiosis was reported in mice, nonhuman primates, and females with endometriosis. Animal models of endometriosis demonstrated the effects of the gut microbiome on lesion growth and vice versa. The immune system mediated by the microbiota-gut-reproductive tract axis triggers an inflammatory response that damages reproductive tract tissue, which possibly leads to endometriosis. However, whether the alteration of eubiosis (a balanced microbiota) to dysbiosis is a cause or a result of endometriosis is unclear. In conclusion, this review provides an overview of the relationship between the gut and reproductive tract microbiome and endometriosis, focusing on the mechanisms by which dysbiosis may increase the risk of disease.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"19 1","pages":"43"},"PeriodicalIF":2.3,"publicationDate":"2023-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/11/08/br-19-01-01626.PMC10265574.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9659971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical, microbiological, immunological and hormonal profiles of patients with granulomatous mastitis. 肉芽肿性乳腺炎患者的临床、微生物学、免疫学和激素特征。
IF 2.3
Biomedical reports Pub Date : 2023-05-18 eCollection Date: 2023-06-01 DOI: 10.3892/br.2023.1624
Nawzad K Esmaeil, Abdulwahid M Salih, Zuhair D Hammood, Lana R A Pshtiwan, Ari M Abdullah, Fahmi H Kakamad, Hiwa O Abdullah, Gasha S Ahmed, Berun A Abdalla, Rawezh Q Salih
{"title":"Clinical, microbiological, immunological and hormonal profiles of patients with granulomatous mastitis.","authors":"Nawzad K Esmaeil,&nbsp;Abdulwahid M Salih,&nbsp;Zuhair D Hammood,&nbsp;Lana R A Pshtiwan,&nbsp;Ari M Abdullah,&nbsp;Fahmi H Kakamad,&nbsp;Hiwa O Abdullah,&nbsp;Gasha S Ahmed,&nbsp;Berun A Abdalla,&nbsp;Rawezh Q Salih","doi":"10.3892/br.2023.1624","DOIUrl":"10.3892/br.2023.1624","url":null,"abstract":"<p><p>Various studies on the etiology and other aspects of granulomatous mastitis (GM) have been performed; however, a lot of controversies have arisen. The present study aimed to present the clinicopathological findings and identify the sensitivity and resistance of isolated bacteria in patients with GM. In this cross-sectional study 63 female patients with a confirmed histopathological diagnosis of GM were included. A core needle biopsy was conducted for the patients to obtain a sample for histopathological examination and bacterial culture. In total, 46 types of antibiotics were used to determine the sensitivity and resistance of each isolated bacterial species. All the medical and clinical records of the patients were acquired through the completion of a questionnaire form in person or, if necessary, through the evaluation of their medical records in the database of the relevant center. The majority of the patients were in the premenopausal or perimenopausal period. GM was unilateral in 58.7% of the patients. The most common symptom was pain, followed by fever and chills. The mean ranges of the erythrocyte sedimentation rate, C-reactive protein, IL-6, IL-17, C5a, white blood count, neutrophil-to-lymphocyte ratio, and prolactin tests were significantly elevated in comparison to the normal ranges. In total, nine different bacterial species were isolated from the bacterial culture of the core biopsy samples, and 50% of the isolated bacterial species were sensitive to trimethoprim-sulfamethoxazole. Since there is no consensus on the etiology of GM, any additional studies related to this aspect expand the current understanding of this puzzling condition.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"18 6","pages":"41"},"PeriodicalIF":2.3,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/32/br-18-06-01624.PMC10265128.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信